Medical network - April 6, the vaccine as a whole in the pharmaceutical sector cost-benefit ratio highest small molecule, is to determine the effectiveness and safety. As a series of policies to boost, the industry generally believe that this year's vaccine industry is expected to usher in a turning point. So, from the point of therelease of vaccine, in 2017 start?
Therelease of vaccine management system in the country, used as a vaccine is available before the last important pass, to ensure that the vaccine is safe and effective. In "much starker choices-and graver consequences-in" start, countries have enacted a series of policy measures to encourage, support and standardize the development of vaccine industry. Has passed a quarter of the first year of opening, 1 to 2, 2017 statistical data also fresh therelease of vaccine.
1-2 month overall slightly down compared to the same batch of sign
According to statistics, 1 to 2, 2017, 54.54 million vaccine batch sign, overall year-on-year fell slightly in 2016. Influenced by factors such as public holidays, vaccine group signed in January 2017, volume rose by about 31%, falling by around 31% in February.
2 kinds of vaccine group signed quantity proportion increased dramatically
January and February, 2017, 2 kinds of vaccine in a batch sign on the number of vaccine accounted for 56.30%, accounted for 43.70%, thus sign 2 kinds of vaccine batch quantity compared with the type of vaccine. Among them, 2 kinds of vaccine group signed in January 2017 the amount accounts for more than 62%, February 2 kinds of vaccine batch quantity accounted for nearly 47%. Compared with the same period in 2016, 2 kinds of vaccine accounted for a significant increase in.
Domestic enterprises vaccine accounted for 96%
In February, 2017, 1-2016 number of sign in vaccines, such as hepatitis b vaccine, epidemic encephalitis vaccine, rabies vaccine varieties is given priority to, and most of the domestic enterprise supply.
Private enterprises accounted for three seats, shenzhen KTS
January and February 2017, vaccine batches of five before you sign the amount of domestic enterprises, private enterprises three, two state-owned enterprises. Among them, shenzhen conde to sign 13.06 million vaccine batch quantity at the top.
The recombinant hepatitis b vaccine (saccharomyces cerevisiae) is the only varieties, shenzhen conde biological group signed respectively with 10 ug and 20 ug two specifications. Currently on the market for 10 ug and 20 ug specifications of the hepatitis b vaccine demand is bigger, so as to improve the two specifications of the hepatitis b vaccine batch quantity.
In addition, 1 to 2, 2017 batches of five before you sign the quantity, the second to fifth enterprises have more than two batch of vaccine varieties.
The hepatitis b vaccine group signed quantity
Safe, effective and plenty of hepatitis b vaccine to control the spread of hepatitis b virus play a decisive role. With increasing social awareness of hepatitis b, hepatitis b vaccine increased demand. Thus, 1 to 2, 2017, the hepatitis b vaccine batch sign volume reached 15.7758 million, more than any other breed, followed by epidemic cerebrospinal meningitis vaccines and rabies vaccine.
The first five vaccine varieties specific brand analysis
The hepatitis b vaccine
At present, the use of the hepatitis b vaccine is divided into: recombinant hepatitis b vaccine (saccharomyces cerevisiae), (han) sunni yeast recombinant hepatitis b vaccine and recombinant hepatitis b vaccine (CHO cells) 3 kinds. January and February, carries on the hepatitis b vaccine batch production enterprises have issued by shenzhen conde and north China pharmaceutical zintan biological two. Among them, shenzhen conde occupied nearly 83% of the number of sign, be a leader in the field.
Meningitis vaccine
At present, the listing of epidemic cerebrospinal meningitis vaccines are A group of meningococcal polysaccharide vaccine, A group of group C meningococcal polysaccharide vaccine, A group of group C meningococcal polysaccharide conjugate vaccine, ACYW135 group of meningococcal polysaccharide vaccine, by wuhan, birth, Watson, made by hualan bio-engineering and other domestic enterprise supply. January and February, with birth, Watson, Beijing intellectual flicker flying bamboo, Luo Yi (wuxi) biological sign of epidemic cerebrospinal meningitis vaccine group. Among them, the birth had a batch of sign, the largest proportion is as high as 47.56%.
Rabies vaccine
Rabies vaccine is mainly used in our country some diploid rabies vaccine (HDCV), Vero cell rabies vaccine (PVCV) and rat renal cell rabies vaccine, mainly supply enterprises with ningbo RongAn creature, and guangzhou cheng, changchun longevity biological liaoning cheng da, etc. January and February, up to 10 companies to sign the rabies vaccine group. Among them, the changchun longevity would take most of sign, up to 39.88%.
Ma gills wind vaccines
January and February, there is the temple of heaven in Beijing, Beijing people sea creatures, birth, firm sinovac vaccine technology (dalian) co., LTD. And Shanghai have 5 companies sign ma gills wind vaccine group. Sign among them, the temple of heaven in Beijing batch quantity, take 1 to 2 month ma gills wind vaccine group signed half of sea creatures and birth followed by Beijing people.
Polio vaccine
At present our country to sign of polio vaccine Sabin main plant inactivated polio, polio inactivated vaccine, oral Ⅰ Ⅲ poliomyelitis live attenuated (human diploid cells) and poliomyelitis live attenuated sugar pill (human diploid cells). January and February, there is the temple of heaven in Beijing, sanofi Pasteur and Chinese academy of medical sciences institute of medical biology to sign. It is important to note that by the Chinese academy of medical sciences institute of medical biology 30 years research and development of the world's first Sabin strains inactivated polio since listed market expands unceasingly, January and February take 23.81% of the batch quantity. |
